Cases 11 - 20 of 151
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND et al v. CELGENE CORPORATION et al
as 2:2022cv06694
Plaintiff:
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND and JACKSONVILLE POLICE OFFICERS AND FIRE FIGHTERS HEALTH INSURANCE TRUST
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Eli Lilly and Company v. Dr. Reddys Laboratories, Ltd. et al
as 1:2022cv01355
Plaintiff:
Eli Lilly and Company
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI R&D MANAGEMENT CO., LTD. et al v. DR. REDDYS LABORATORIES, INC. et al
as 3:2022cv05950
Plaintiff:
EISAI R&D MANAGEMENT CO., LTD., EISAI CO., LTD. and EISAI INC.
Defendant:
DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv01102
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Dr. Reddys Laboratories Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ADELMAN et al v. APOTEX CORPORATION et al
as 2:2022cv03179
Plaintiff:
David Adelman, Glen Horay, Steve Monillas and others
Defendant:
APOTEX CORPORATION, PATHEON MANUFACTURING SERVICES LLC, WATSON LABORATORIES, INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SUPERNUS PHARMACEUTICALS, INC. v. DR. REDDY'S LABORATORIES, LTD. et al
as 3:2022cv04705
Plaintiff:
SUPERNUS PHARMACEUTICALS, INC.
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR REDDY'S LABORATORIES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Inc. et al
as 1:2022cv00498
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv00298
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
